In a rare head-to-head analysis, Yale's health system evaluated the statistical performance of six early warning scores on the same clinical data from seven of its hospitals, publishing its results Tuesday in JAMA Network Open. It revealed that some clinical AI models aren't all they're cracked up to be.
A nonprofit biotechnology company based in Philadelphia has received $60 million from a TED initiative that funds "big ideas." The company, Every Cure, is using the money to further its mission of employing AI to help match existing treatments to new diseases. The company's focus stems from the personal experience of one of its founders, David Fajgenbaum, an immunologist and associate professor at University of Pennsylvania, who credits a repurposed drug with saving his life.
Late Tuesday night, Carequality released new information about its investigation into the dispute between electronic health records vendor Epic Systems and health data startup Particle Health that has now escalated into an antitrust lawsuit.
The closure of a technology company can have far-reaching implications to an enterprise’s daily operations, especially when it happens suddenly, or in a bankruptcy or dissolution process. Dealing with this requires a rapid response capacity, but also a proactive strategy to help navigate next steps.
Big Blue is betting that big iron for AI is a worthwhile investment for enterprise CIOs. With so much critical data still running through these legacy systems, IT leaders with hopes for AI might just agree.